Skip to main content

4D Molecular Therapeutics, Inc.

FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001650648

In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding 4D Molecular Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of FDMT: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1532157+6
Shares50.7M5.25M58.0M+12.6M (+27.8%)
Value$471.4M$48.9M$771.2M+$348.8M (+82.6%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to FDMT in Q2 2026
InstitutionSharesValue% of portfolio
Jupiter Topco LLC5,746,289$76.5M0.03%
T. Rowe Price Investment Management, Inc.2,511,887$33.4M0.02%
Diadema Partners LP571,107$7.60M2.68%
Acuta Capital Partners, LLC507,801$6.75M4.71%
Catalio Capital Management, LP471,254$6.27M1.18%
Brevan Howard Capital Management LP176,850$2.35M0.03%
Persistent Asset Partners Ltd145,585$1.94M0.61%
Greenland Capital Management LP72,257$961.0K0.18%
SG Americas Securities, LLC66,440$884.0K0.00%
Fisher Asset Management, LLC65,751$874.5K0.00%
Alps Advisors Inc53,056$705.6K0.00%
TD Asset Management Inc51,482$684.7K0.00%
Birchview Capital, LP48,505$645.1K0.30%
Allspring Global Investments Holdings, LLC37,200$472.1K0.00%
Omers Administration Corp27,800$369.7K0.00%
Canada Pension Plan Investment Board24,700$328.5K0.00%
Jain Global LLC23,537$313.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.14,899$198.2K0.00%
Axq Capital, LP13,964$185.7K0.02%
LPL Financial LLC12,441$165.5K0.00%
Graham Capital Management, L.P.12,003$159.6K0.00%
Susquehanna Fundamental Investments, LLC11,145$148.2K0.00%
Optiver Holding B.V.1,782$23.7K0.00%
Pacer Advisors, Inc.747$10.0K0.00%
Allied Private Wealth LLC740$9.63K0.01%
Planning Strategies Inc.502$6.68K0.00%
Clear Street Markets LLC432$5.75K0.00%
Caitong International Asset Management Co., Ltd59$7850.00%
Quarry LP27$3590.00%
Clearstead Advisors, LLC3$400.00%

Sold out (24)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (2)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FDMT in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Janus Henderson Group PLC5,247,151$48.9M
CWM, LLC4,806$44.7K